Immune privilege in hair growth
- PMID: 1714928
- DOI: 10.1111/1523-1747.ep12481002
Immune privilege in hair growth
Abstract
Immunostaining techniques were used to investigate the relationship between immune cells, proteoglycan, and class I MHC distribution in skin during the hair cycle in rats. The growth stage, anagen, was characterized by absence of class I MHC staining on most cells of the lower follicle and presence of chondroitin proteoglycan in the follicle sheath and dermal papilla. Immune cells were few in number and not associated with follicles. Dramatic changes were observed during regression in catagen; class I MHC was expressed on all follicle epithelium, large numbers of activated macrophages aggregated around the follicles, and the chondroitin proteoglycans disappeared from the follicle sheath and dermal papilla. During the resting stage, telogen, class I MHC remained on cells of the secondary germ, but macrophages and chondroitin proteoglycans were absent. These observations lead us to propose a hypothesis of immune privilege in hair growth.
Similar articles
-
Distribution of proteoglycans during the hair growth cycle in human skin.J Invest Dermatol. 1991 Feb;96(2):191-5. doi: 10.1111/1523-1747.ep12461019. J Invest Dermatol. 1991. PMID: 1704038
-
Distribution of two basement membrane proteoglycans through hair follicle development and the hair growth cycle in the rat.J Invest Dermatol. 1990 Jan;94(1):65-70. doi: 10.1111/1523-1747.ep12873363. J Invest Dermatol. 1990. PMID: 1688599
-
Association of versican with dermal matrices and its potential role in hair follicle development and cycling.J Invest Dermatol. 1995 Sep;105(3):426-31. doi: 10.1111/1523-1747.ep12321131. J Invest Dermatol. 1995. PMID: 7665924
-
Hair follicle proteoglycans.J Invest Dermatol. 1993 Jul;101(1 Suppl):60S-64S. doi: 10.1111/1523-1747.ep12362642. J Invest Dermatol. 1993. PMID: 8326155 Review.
-
The hair follicle and immune privilege.J Investig Dermatol Symp Proc. 2003 Oct;8(2):188-94. doi: 10.1046/j.1087-0024.2003.00807.x. J Investig Dermatol Symp Proc. 2003. PMID: 14582671 Review.
Cited by
-
SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.Oncotarget. 2017 May 16;8(20):33432-33443. doi: 10.18632/oncotarget.16504. Oncotarget. 2017. PMID: 28418931 Free PMC article.
-
What causes alopecia areata?Exp Dermatol. 2013 Sep;22(9):609-26. doi: 10.1111/exd.12209. Exp Dermatol. 2013. PMID: 23947678 Free PMC article. Review.
-
Tissue engineering strategies for human hair follicle regeneration: How far from a hairy goal?Stem Cells Transl Med. 2020 Mar;9(3):342-350. doi: 10.1002/sctm.19-0301. Epub 2019 Dec 26. Stem Cells Transl Med. 2020. PMID: 31876379 Free PMC article.
-
Quiescent Tissue Stem Cells Evade Immune Surveillance.Immunity. 2018 Feb 20;48(2):271-285.e5. doi: 10.1016/j.immuni.2018.02.001. Immunity. 2018. PMID: 29466757 Free PMC article.
-
Pathophysiology of Alopecia Areata in the Pediatric Patient.Pediatr Dermatol. 2025 Mar;42 Suppl 1(Suppl 1):24-30. doi: 10.1111/pde.15842. Pediatr Dermatol. 2025. PMID: 40044623 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials